Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 277, Issue 3 21-3, 1999, Pages

  Hattori, Noboru ^a   Sisson, Thomas H ^a   Xu, Yin ^a   Desai, Tushar J ^a   Simon, Richard H ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Fibrinolysis; Gene therapy; Inflammation

Indexed keywords

FIBRIN; UROKINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONING VECTOR; FIBRINOLYSIS; FLOW CYTOMETRY; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LUNG CLEARANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR BINDING; SPECIES DIFFERENCE;

EID: 0032886075     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1999.277.3.l573     Document Type: Article

References (32)

1. Bachofen, A., and E. R. Weibel. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am. Rev. Respir. Dis. 116: 589-615, 1977.
2. Basset, F., V. J. Ferrans, P. Soler, T. Takemura, Y. Fukuda, and R. G. Crystal. Intraluminal fibrosis in interstitial lung disorders. Am. J. Pathol. 122: 443-461, 1986.
3. Bertozzi, P., B. Astedt, L. Zenzius, K. Lynch, F. LeMaire, W. Zapol, and H. J. Chapman. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N. Engl. J. Med. 322: 890-897, 1990.
4. Blasi, F., and P. Verde. Urokinase-dependent cell surface proteolysis and cancer. Semin. Cancer Biol. 1: 117-126, 1990.
5. Bugge, T. H., M. J. Flick, M. J. Danton, C. C. Daugherty, J. Romer, K. Dano, P. Carmeliet, D. Collen, and J. L. Degen. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc. Natl. Acad. Sci. USA 93: 5899-5904, 1996.
6. Bugge, T. H., T. T. Suh, M. J. Flick, C. C. Daugherty, J. Romer, H. Solberg, V. Ellis, K. Dano, and J. L. Degen. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J. Biol. Chem. 270: 16886-16894, 1995.
7. Carmeliet, P., and D. Collen. Gene manipulation and transfer of the plasminogen and coagulation system in mice. Semin. Thromb. Hemost. 22: 525-542, 1996.
8. Carmeliet, P., L. Schoonjans, L. Kieckens, B. Ream, J. Degen, R. Bronson, R. De Vos, J. J. van den Oord, D. Collen, and R. C. Mulligan. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368: 419-424, 1994.
9. Chapman, H. A., C. L. Allen, and O. L. Stone. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am. Rev. Respir. Dis. 133: 437-443, 1986.
10. Chucholowski, N., M. Schmitt, R. Rettenberger, E. Schuren, N. Moniwa, L. Gortezki, O. Wilhelm, U. Weidle, F. Janicke, and H. Graeff. Flow cytofluorometric analysis of the urokinase receptor (uPAR) on tumor cells by fluorescent uPA-ligand or monoclonal antibody #3936. Fibrinolysis 6, Suppl. 4: 95-102, 1992.
11. Eitzman, D. T., R. D. McCoy, X. Zheng, W. P. Fay, T. Shen, D. Ginsburg, and R. H. Simon. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest. 97: 232-237, 1996.
12. Ellis, V., N. Behrendt, and K. Dano. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J. Biol. Chem. 266: 12752-12758, 1991.
13. Fukuda, Y., M. Ishizaki, Y. Masuda, G. Kimura, O. Kawanami, and Y. Masugi. The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am. J. Pathol. 126: 171-182, 1987.
14. Gross, T. J., R. H. Simon, and R. G. Sitrin. Expression of urokinase-type plasminogen activator by rat pulmonary alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 3: 449-456, 1990.
15. Hattori, N., T. H. Sisson, Y. Xu, and R. H. Simon. Upregulation of fibrinolysis by adenovirus-mediated transfer of urokinase-type plasminogen activator genes to lung cells in vitro and in vivo. Hum. Gene Ther. 10: 215-222, 1999.
16. Idell, S., K. K. Gonzalez, C. K. MacArthur, C. Gillies, P. N. Walsh, J. McLarty, and R. S. Thrall. Bronchoalveolar lavage procoagulant activity in bleomycin-induced lung injury in marmosets. Characterization and relationship to fibrin deposition and fibrosis. Am. Rev. Respir. Dis. 136: 124-133, 1987.
17. Idell, S., K. K. James, C. Gillies, and D. S. Fair. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition. Am. J. Pathol. 137: 387-389, 1989.
18. Idell, S., K. K. James, E. G. Levin, B. S. Schwartz, N. Manchanda, R. J. Maunder, T. R. Martin, J. McLarty, and D. S. Fair. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J. Clin. Invest. 84: 695-705, 1989.
19. Kotani, I., A. Sato, H. Hayakawa, T. Urano, Y. Takada, and A. Takada. Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb. Res. 77: 493-504, 1995.
20. Kuhn, C. The pathogenesis of pulmonary fibrosis. Monogr. Pathol. 36: 78-92, 1993.
21. Kuhn, C., J. Boldt, T. J. King, E. Crouch, T. Vartio, and J. A. McDonald. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am. Rev. Respir. Dis. 140: 1693-1703, 1989.
22. Lijnen, H. R., B. Van Hoef, and D. Collen. Characterization of the murine plasminogen/urokinase-type plasminogen-activator system. Eur. J. Biochem. 241: 840-848, 1996.
23. Min, H. Y., R. Semnani, I. F. Mizukami, K. Watt, R. F. Todd III, and D. Y. Liu. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J. Immunol. 148: 3636-3642, 1992.
24. Mohanam, S., R. Sawaya, I. McCutcheon, F. Ali-Osman, D. Boyd, and J. S. Rao. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res. 53: 4143-4147, 1993.
25. Olman, M. A., N. Mackman, C. L. Gladson, K. M. Moser, and D. J. Loskutoff. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J. Clin. Invest. 96: 1621-1630, 1995.
26. Plow, E. F., D. E. Freany, J. Plescia, and L. A. Miles. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J. Cell Biol. 103: 2411-2420, 1986.
27. Powell-Jones, C. H. Rapid SDS-PAGE zymography of plasminogen activators. Thromb. Res. 49: 299-302, 1988.
28. Schafer, B. M., K. Maier, U. Eickhoff, R. F. Todd, and M. D. Kramer. Plasminogen activation in healing human wounds. Am. J. Pathol. 144: 1269-1280, 1994.
29. Schmitt, M., N. Chucholowski, E. Busch, D. Hellmann, B. Wagner, L. Goretzki, F. Janicke, W. A. Gunzler, and H. Graeff. Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cells. Semin. Thromb. Hemost. 17: 291-302, 1991.
30. Simon, R. H., T. J. Gross, J. A. Edwards, and R. G. Sitrin. Fibrin degradation by rat pulmonary alveolar epithelial cells. Am. J. Physiol. 262 (Lung Cell. Mol. Physiol. 6): L482-L488, 1992.
31. Solberg, H., D. Lober, J. Eriksen, M. Ploug, E. Ronne, N. Behrendt, K. Dano, and G. Hoyer-Hansen. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator. Eur. J. Biochem. 205: 451-458, 1992.
32. Strickland, J. E., D. A. Greenhalgh, A. Koceva-Chyla, H. Hennings, C. Restrepo, M. Balaschak, and S. H. Yusipa. Development of murine epidermal cell lines which contain, an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res. 48: 165-169, 1988.